India Promotes Domestic Manufacturing Of APIs To Become ‘Self-Reliant’
IPA’s ‘Vision 2030’ Identifies Opportunities For Indian Pharma Sector
To ensure delivery of affordable healthcare to citizens, the Indian government’s department of pharmaceuticals has issued a notification highlighting the Production Linked Incentive Scheme that intends to boost domestic manufacturing of identified KSMs, intermediates and APIs by attracting large investments in the sector.
